Dewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. It offers genetically linked condensatopathy discovery engines, machine-learning-based image analysis tools, engineered cell lines collection, condensate-direct medicinal chemistry, and other solutions. The company uses biomolecular condensates to develop drugs for neurodegeneration, cancer, inflammation, infectious diseases, metabolic diseases, and rare genetic disorders.